BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34954689)

  • 1. Tumor microenvironment characterization in esophageal cancer identifies prognostic relevant immune cell subtypes and gene signatures.
    Zhang Y; Zhu M; Mo J; Xian L
    Aging (Albany NY); 2021 Dec; 13(24):26118-26136. PubMed ID: 34954689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures.
    Zeng D; Li M; Zhou R; Zhang J; Sun H; Shi M; Bin J; Liao Y; Rao J; Liao W
    Cancer Immunol Res; 2019 May; 7(5):737-750. PubMed ID: 30842092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Prognostic Related Genes of Tumor Microenvironment Derived From Esophageal Cancer Patients.
    Yuan W; Yan J; Liu H; Li L; Wu B; Guo C; Zhang M
    Pathol Oncol Res; 2021; 27():589662. PubMed ID: 34257539
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor microenvironment characterization in colorectal cancer to identify prognostic and immunotherapy genes signature.
    Guo XW; Lei RE; Zhou QN; Zhang G; Hu BL; Liang YX
    BMC Cancer; 2023 Aug; 23(1):773. PubMed ID: 37596528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDKL3 shapes immunosuppressive tumor microenvironment and initiates autophagy in esophageal cancer.
    Bi Y; Liu J; Qin S; Ji F; Zhou C; Yang H; Zhou S
    Front Immunol; 2024; 15():1295011. PubMed ID: 38562942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Tumor Microenvironment in Lung Adenocarcinoma Identifies Immune Signatures to Predict Clinical Outcomes and Therapeutic Responses.
    Chen D; Wang Y; Zhang X; Ding Q; Wang X; Xue Y; Wang W; Mao Y; Chen C; Chen Y
    Front Oncol; 2021; 11():581030. PubMed ID: 33747907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Microenvironment Characterization in Glioblastoma Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures.
    Zhang J; Xiao X; Zhang X; Hua W
    J Mol Neurosci; 2020 May; 70(5):738-750. PubMed ID: 32006162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironment characterization in head and neck cancer identifies prognostic and immunotherapeutically relevant gene signatures.
    Huo M; Zhang Y; Chen Z; Zhang S; Bao Y; Li T
    Sci Rep; 2020 Jul; 10(1):11163. PubMed ID: 32636465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures.
    Wu Q; Wang L; Wei H; Li B; Yang J; Wang Z; Xu J; Zhou YL; Zhang B
    Int Immunopharmacol; 2020 Jun; 83():106477. PubMed ID: 32278127
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Zhang R; Wang H; Xiao J; Lu J; Li M; Zhou Y; Sun H; Liu L; Huang T; Zhao Q
    DNA Cell Biol; 2023 Jan; 42(1):27-42. PubMed ID: 36638349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor microenvironment characterization in cervical cancer identifies prognostic relevant gene signatures.
    Peng L; Hayatullah G; Zhou H; Chang S; Liu L; Qiu H; Duan X; Han L
    PLoS One; 2021; 16(4):e0249374. PubMed ID: 33901225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving ovarian cancer treatment decision using a novel risk predictive tool.
    Xu Z; Song J; Cao L; Rong Z; Zhang W; He J; Li K; Hou Y
    Aging (Albany NY); 2022 Apr; 14(8):3464-3483. PubMed ID: 35439731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
    Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
    Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokines and Their Receptors: Predictors of Therapeutic Potential in Tumor Microenvironment on Esophageal Cancer.
    Huang CG; Liu Q; Zheng ST; Liu T; Tan YY; Peng TY; Chen J; Lu XM
    Dig Dis Sci; 2024 May; 69(5):1562-1570. PubMed ID: 38580886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the Tumor Microenvironment in Osteosarcoma Identifies Prognostic- and Immunotherapy-Relevant Gene Signatures.
    Tan J; Feng X; Wu H; Yang B; Shi M; Xie C; Su Z; Li L; Luo M; Zuo Z; Zhu S; Yang J; Lin L
    J Immunol Res; 2022; 2022():6568278. PubMed ID: 36065454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-Cancer Molecular Characterization of m
    Zhu J; Xiao J; Wang M; Hu D
    Front Oncol; 2020; 10():618374. PubMed ID: 33585244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
    Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
    Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Bioinformatics Analysis Identifies Tumor Microenvironment and Immune-related Genes in Small Cell Lung Cancer.
    Song Y; Sun Y; Sun T; Tang R
    Comb Chem High Throughput Screen; 2020; 23(5):381-391. PubMed ID: 32264809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic subtypes and immune landscapes in esophageal squamous cell carcinoma: prognostic implications and potential for personalized therapies.
    Yu XW; She PW; Chen FC; Chen YY; Zhou S; Wang XM; Lin XR; Liu QL; Huang ZJ; Qiu Y
    BMC Cancer; 2024 Feb; 24(1):230. PubMed ID: 38373930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic Pathway Signatures.
    Li J; Qiu J; Han J; Li X; Jiang Y
    Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.